An update on clinical trials of (synthetic) psilocybin as a treatment for depression, heading into phase three.
COMPASS' Published Results Take its Psilocybin into Final Phase of Clinical Trials - Lucid News
The results of the company’s Phase 2b trial raise concerns around safety, efficacy, and money, suggesting key questions to be addressed in Phase 3.
lucid.news